Future research in CINV focuses on understanding the underlying toxicological mechanisms and developing more effective prevention and treatment strategies. Innovations in pharmacogenomics and personalized medicine are expected to play a significant role in tailoring antiemetic therapies. Additionally, the development of new drug delivery systems and formulations may enhance the efficacy and safety of existing treatments.
In conclusion, CINV is a complex phenomenon with significant implications for patient care in oncology. A thorough understanding of its toxicological basis is essential for developing effective management strategies and improving patient outcomes.
